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Objective: To determine the clinical presentations, of gastric stromal tumors with diagnostic methods, patholog 
outcome after surgery. Y and 
Study Design: A case series. 
Duration and Setting: From January 1988 to December 2002 at The Aga Khan University Hospital, Karachi. 
Patients and Methods: All patients of age 14 years and above, diagnosed histopathologically to have gastric stro 
tumors were included. The data of these patients was collected retrospectively from January 1988 to December 1998 mat 
prospectively from January 1999 to December 2002. All the patients were studied as a single group. 'and 
Results: There were 11 patients. Their mean age was 54 years, with 8 males and 3 females. Five patients presented With 
upper gastrointestinal bleeding, and 4 with lower gastrointestinal bl.eeding. Eight patients had pain ·,n epigastrium and 2 
had vomrtrng. Upper gastrorntestmal endoscopy was done rn all patrents, and ultrasound was done rn 4 patients. CT scan 
was done in 7 patients. Pre-operative diagnosis could be made in 6 patients. Only one patient had liver metastasis. Wedge 
resection was performed in 5 proximal gastrectomy with gastroesophageal anastomosis in 3, and partial gastrectomy with 
gastrojejunostomy in another 3 patients. The mean tumor size was 8.0 centimeters. Two patients had benign, 2 had 
intermediate and 7 had malignant tumors. The mean duration of follow-up was 41 months. Follow-up was completed in 
8 patients, out of whom 6 were alive, arid 2 patients expired due to other causes at the time of completion of this study. 
Conclusion: Gastric stromal tumors are uncommon. Larger gastric stromal tumors are usually symptomatic with 
gastrointestinal bleeding as a common presentation. Immunohistochemical techniques are required for the diagnosis. 
Complete surgical resection is the curative therapy. 
KEYWORDS: Gastric stromal fumors. Diagnosis. Treatment. Outcome. 
Gastric stromal tumors are uncommon) Many of such tumors 
may not originate from smooth muscles', therefore, these 
tumors may be classified as GIST i.e. Gastrointestinal stromal 
tumors and in relation to the stomach as gastric stromal 
tumors.3 
These tumors were classified depending on the type of tissue 
from which they arisef that is smooth musclesf nervous tissue 
or both of them.• With the advent of the electron microscopy 
and inununohistochemical techniques these tumors are now 
classified as benign, intermediate and malignant, depending 
upon the tumor size and mitotic count.4 Immuno-
hlstochemical techniques analyse the positivity of vimentin, 
desmin, anti smooth muscle antibodies and S-100 to 
differentiate between different tumors.s Although prediction 
of the biological behaviour of these tumors is often difficult, 
but in general malignant stromal tumors are mitotically more 
active, more cellular, larger in size, and having adjacent organ 
invasion.' The majority of gastric stromal tumors are grossly 
well circumscribed, even those that prove to be malignant? 
Department of Surgery, The __ ~~-~--~~-~n University Hospital, Karachi, Pakistan. 
Correspondence: Dr. DiiQar Hussain, Surgery Department, Level 5 West, 
Dubai Hospital, P.O. Box. 7272, Oubai, United Arab Emirates. 
E'='mail: docdi!dar@yahoo.com 
······················-·-· 
Received July 26, 2004; accepted September 3, 2006. 
696 
Most of the gastric stromal tumors are asymptomatic, but 
slowly growing tumors may present as symptomatic masses.a 
Despite advances in technology, the pre-operative diagnosis 
of gastric stromal tumors is often difficult. Helpful 
investigations include: upper gastrointestinal endoscopy, 
ultrasonography, CT scan and endoscopic ultrasound' As 
gastric stromal tumors are usually radioresistant and 
insensitive to chemotherapeutic agentsf the only curative 
therapy is adequate surgical excision.6 Metastatic disease is 
most common in liver and peritoneum.? Metastasis to local 
lymph nodes does not occur, thus there does not appear to 
be a need for lymph node dissection.!' 
The objectives of the study were to determine the cliniCill 
presentations, diagnostic methods and outcome after surgery of 
these rare tumors at The Aga Khan University Hospital, Karachi. 
pATIENTS AND METI-IOOS 
It was a case series with combined retrospective and 
prospective review conducted at The Aga Khan University 
Hospital, Karachi from January 1988 to December 2002. The 
data was collected retrospectively from 1988 to !998, and 
. IS prospectively from 1999 to December 2002. All adult pat,en 
of age 14 years and above, diagnosed by histopathology, to 
have gastric stromal tumors were included in the studY. 
Patients less than 14 years of age, and patients with 
incomplete medical record were excluded. 
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. , deJ1l0 graphic data, presentations, diagnostic methods 
. and the type of surgical procedure performed were 
All the slides were reviewed by the pathologist. The 
were classified according to the new classification 
benign, intermediate and malignant. The reasons for 
:.:.lrc<teJI'"" i:Arrussron after the discharge from the hospital, and follow 
"~"""'o'~patients were also reviewed. There were 4 patients 
studied prospectively. Since all their features were 
the retrospective group, therefore, all patients were 
as a single group. TGM (Tumor, Grade, Metastasis) 
was used to stage the disease. 
were 11 patients. The mean age was 54 years. There 
::1<1''"""'. and 3 female patients. Ischemic heart disease was 
?.J,~rr11orb1:dity in 4 patients, hypertension in 3, liver cirrhosis 
;11\ilrheumatoJa arthritis in 1, smoking in 2, and goiter in 1 
clinical features and the duration of these features 
in Table I. 
5 32 
· · hemoglobin was less than 10 gm/ dl in 3 patients, and 8 
lfpatienrtshad hemoglobin of more than 10gm/ ell at the time of 
If •jmissi011. The liver function tests were normal in all the 
rnmen'ts. Upper gastrointestinal endoscopy was used as a 
iilgrJostic modality in all of these patients. The yield of the 
gastrointestinal endoscopy was small and only 
could be diagnosed to have gastric stromal tumors, 
d''' .enrdo:3co·pic biopsy. The endoscopy showed ulcer in 
patients, nodular lesions in 2, gastritis in 3, 
~ bi~~:~~~;:'!~~~in l, and gastric outlet obstruction in 1 patient. ~ of abdomen was done in 4 patients. It 
~owed a mass anterior to the pancreas in one patient. 
The pre-operative C.T scan was done in 7 patients. ln 6 
patients, it revealed a mass in stomach. In one patienC it 
a mass inferior to the antral part of the stomach. No 
metastasis or ascites was detected pre-operatively in 
lhese patients. 
With the help of these diagnostic modalities, the pre-operative 
Provisional diagnosis of a gastric stromal tumor was made in 
6 patients. Wedge resection with negative tumor margin was 
!'erfonned in 5 patients. In 3 patients, proximal gastrectomy 
· gastroesophageal anastomosis was performed. A partial 
gastrectomy and gastrojejunostomy was performed in 
3 yatients because the tumor was in the pylorus of the 
;lornach. One patient was found to have liver metastasis and 
· Patients had tumor rupture, detected per-operatively. 
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The size of the tumor ranged from 3.5cm to·21cm, with a mean 
diameter of 8.0cm.The slides of all these patients were 
reviewed by the histopafuologist, and these tumors were 
reclassified according to a new classification system of Amin 
et al. Two patients had benign tumors, 2 had intermediate, 
and 7 patients had malignant tumors. One patient had stage I 
disease, 3 patients had stage II, 3 patients had stage III, one 
patient had stage IV A, and 3 patients had stage IV B disease. 
Injury to splenic vessels occurred in one patient, during 
surgery, leading to hemorrhage and splenectomy was done. 
He was shifted to ICU, where he developed pneumonia and 
ARDS, leading to death. One patient developed urinary tract 
infection postoperatively, and he was treated with antibiotics. 
The mean hospital stay was 11 days. 
Four patients were re-admitted with pain epigastrium due to 
acid peptic disease, 2 patients with upper gastrointestinal 
bleeding, one patient with ischemic heart disease and one 
patient with hepatic coma. One patient who had liver 
metastasis was admitted for chemotherapy. 
The mean duration of follow up was 41 months. Two patients 
were lost to follow up, one of them was the patient with liver 
metastasis, and he lost to follow up after 20 months of his 
surgery, and another was lost to follow up 4 months after the 
surgery. Among the remaining 8 patients, 6 patients were alive 
at the time of completion of this study. One patient expired 8 
years after surgery due to ischemic heart disease, and another 
patient expired 3 years and 9 months after the surgery, due to 
liver cirrhosis. 
The stage of the disease, operative procedure and duration of 
survival is shown in Table II. 
Table II Stage of disease, operative procedure and survival. 
S.No. Stage of Operative Swvival in 
disease procedure months 
1 1 Wedge resection 45 (ex~ired) 
2 11 Wedge resection 66 
3 11 Wedge resection 04 (lost to fo!low-u~! 
4 111 Prox. gastrectomy with 
gastroesophag. 
anastomosis 96 ( ex~i red l 
5 111 Wedge resection 54 
6 111 Partial gastrectomy and 
gastrojejunal anastomosis 26 
7 1VA Proximal gastrectomy with 20 (lost to follow-up 
gastroeso~hag.anastomosis after 20 months) 
8 1VB Partial gastrectomy with gastro 
jejunal anastomosis 3S 
9 1VB Proximal gastrectomy with 
gastroesoehag.anastomosis 49 
10 IVB Partial gastrectomy and 
gastrojejunal anastomosis 21 
DrscussroN 
Tumors of smooth muscle origin account for 0.3% of gastric 
lesions.n Many of such tumors may not originate from 
smooth muscles2, and therefore, these tumors are called 
gastric stromal tumors. A significant number of patients 
have their tumors discovered during operation when they 
present with bleeding, perforation, or obstruction.? The 
surgeon is required to formulate adequate therapy usually in 
an acute condition for a rare disease. Most of these tumors are 
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asymptomatic. Symptomatic tumors have varied 
presentations. Gastfo-intestinaJ bleeding was the common 
presentation in this study, occurring in 9 patients. This was 
followed by pain in epigastrium, vomiting, dysphagia and 
anorexia. The incidence of gastrointestinal bleeding as 
reported in the literature is up to 70%.12 However, these are 
usually nonspecific and depend upon the size and location of 
lesion.13 
As pre-operative diagnosis of these tumors is often difficult, in 
the literature pre-operative diagnosis could be made in 
upto 15% of the cases.12 In our series the pre-operative 
provisional diagnosis of gastric stromal tumors was made in 6 
patients. Endoluminal ultrasonography has sensitivity of 80% 
to 100% in detecting gastric stromal tumors and it also 
differentiates benign from the malignant stromal tumors, as 
decribed in the literature.9 A demarcated hypoechoic mass 
that is contiguous with the muscularis propria layer of the 
stomach is characteristic of a stromal tumor.9 Fine needle 
aspiration and core biopsy are also described as pre operative 
diagnostic methods.l4 These modalities were not used in our 
patients. 
Surgical resection of localized gastric stromal tumors is the 
preferred treatment modality. Historically a 1 to 2 em margin 
was thought to be necessary for adequate resection. Recently it 
is demonstrated that the surgical goal should be complete 
resection with negative resection margins, without 
lymphadenectomy.14 In some cases, tumor size and location 
may require extensive surgery, including partial or total 
gastrectomy. Removal of all the gross disease improves the 
outcome even in patients with advanced disease. The regional 
lymphadenectomy would not result in beneficial effects'' 
because majority of these patients present with systemic 
metastasis.'' In the present series, removal of all the gross 
disease was done in 10 patients and one patient had liver 
metastasis. Tumor rupture is said to have an adverse influence 
on the survival of the patients.' In this study, 3 patients had 
tumor rupture, because the tumor had already ulcerated prior 
to surgery. 
Currently a laparoscopic resection of gastric stromal tumors is 
performed in some centres. A study done by Novitsky eta/. 
showed a laparoscopic approach to surgical resection of 
gastric stromal tumors was associated with low morbidity and 
short hospital stay.'' The long-term follow-up (mean 36 
months) in this study showed a disease-free survival of 92%. 
The mean diameter of the gastric stromal tumors as described 
in the literature is upto 7.3 centimeters. In this study, the mean 
diameter is 8.0 centimeters. This seems that patients presented 
in the advanced stage of the disease. The mean follow-up was 
41 months, which is better than the study of Ludwig.!' The 
local recurrence has been reported upto 10% to 12% in the 
literature, but in our study no patient had local recurrence. 
The rates of curative resection for gastric stromal tumors 
ranges from 68% to 90%, and 5 years survival ranges from 32% 
to 63%.14 
A case reported by Shiwani showed 4 years postsurgery 
follow-up in a patient operated for gastric stromal tumor, 
without chemo-radiotherapy that did not show any evidence 
qf disease.l7 In this study one patient expired 8 years after the 
surgery due to ischemic heart disease, but having no evidence 
of the tumor recurrence. 
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------------- ~·' The role of radiotherapy has yet to be dete . ~ 
there is no data available to support the ::•d. Pre5c1\l . ~ 
radiotherapy to these patients. Currentlv it . ll1tstration ~, '# 
k ,, ls desc .b ~ C-kit receptor tyrosine inase is expressed i " ed lha If! 
The tyrosine kinase inhibitor Glivac is the n/hese tu~0 '.· ~o 
designed molecular targeted drug therapy for !rst _ration,~ 1'[fJ 
tumors)S Glivac is indicated in patients Wit~astnc stro~t~~ ~~ 
tumors or with metastatic disease.19 In one unresec!ab~ '~11 
surgical resection, Glivac caused stabilization 0 study, Mt~ 
. . r regre . 
the tumor m 84% of pahents.20 True efficacy is unkno ss,onn~ 
the results of the ongoing prospective trials. Gliv Wn llntij 
given to patients in this study. ac Was not 
CoNCLUSION 
Gastric stromal tumors are uncommon. Larger tu 
usually symptomatic. Immunohistochemical technimors are 
required for the diagnosis. Complete surgical rese qtues '" 
. . c~a 
lead to prolongatwn of bfe, and may be a potential c " 
patients with gastric stromal tumors. Ure for 
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